Form 8-K - Current report:
SEC Accession No. 0001213900-25-021923
Filing Date
2025-03-10
Accepted
2025-03-10 07:45:27
Documents
17
Period of Report
2025-03-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0233702-8k_optimize.htm   iXBRL 8-K 31966
2 AMENDED AND RESTATED EMPLOYMENT LETTER, DATED AS OF MARCH 7, 2025 BY AND BETWEEN ea023370201ex10-1_optimize.htm EX-10.1 31393
3 PRESS RELEASE, DATED MARCH 10, 2025 ea023370201ex99-1_optimize.htm EX-99.1 13829
4 GRAPHIC ex10-1_001.jpg GRAPHIC 15297
5 GRAPHIC ex99-1_001.jpg GRAPHIC 15691
  Complete submission text file 0001213900-25-021923.txt   307141

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE oprx-20250310.xsd EX-101.SCH 3021
7 XBRL LABEL FILE oprx-20250310_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE oprx-20250310_pre.xml EX-101.PRE 22363
19 EXTRACTED XBRL INSTANCE DOCUMENT ea0233702-8k_optimize_htm.xml XML 3671
Mailing Address 260 CHARLES STREET SUITE 302 WALTHAM MA 02453
Business Address 260 CHARLES STREET SUITE 302 WALTHAM MA 02453 248-651-6558
OptimizeRx Corp (Filer) CIK: 0001448431 (see all company filings)

EIN.: 261265381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38543 | Film No.: 25722173
SIC: 7389 Services-Business Services, NEC
(CF Office: 07 Trade & Services)